Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Bone resorption predicts for skeletal complications in metastatic bone disease
2003
Human Milk Composition
2012 Standout
Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment
1996
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
2004 Standout
TGF-β signalling-related markers in cancer patients with bone metastasis
2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
2007
Use of bisphosphonates in cancer patients
1996
Macrophages in immunoregulation and therapeutics
2023 Standout
Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors
2005
Effect of bisphosphonates on pain and quality of life in patients with bone metastases
2009
Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community
2006
Impact of skeletal complications on patients’ quality of life, mobility, and functional independence
2008
Systematic review of bisphosphonates for hypercalcaemia of malignancy
2004
The Epidemiology of Distal Radius Fractures
2012 Standout
Hypercalcemia Associated with Cancer
2005
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
2015
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
2009
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
1998
Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity
1995
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Phosphine-Catalyzed α-P-Addition on Activated Alkynes: A New Route to P−C−P Backbones
2006
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Bisphosphonates: mechanisms of action.
1996
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Studies Comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for Assessment of Pain Intensity in Adults: A Systematic Literature Review
2011 Standout
Biomarkers in Heart Failure
2008 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Cancer Pain Assessment in Clinical Trials. A Review of the Literature (1999–2002)
2005
B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in Patients With CKD: Relationship to Renal Function and Left Ventricular Hypertrophy
2005
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma
2002
Phosphine Organocatalysis
2018 Standout
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
A Dose-Finding Study of Zoledronate in Hypercalcemic Cancer Patients
1999
Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
2008
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Skeletal complications of malignancy
1997 Standout
Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials
2001
Guidelines for the management of thyroid cancer
2014 Standout
Multiple Myeloma
2011 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Oral bisphosphonates
2000
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Bisphosphonates: Mechanisms of Action
1998
A systematic review of the role of bisphosphonates in metastatic disease
2004
Works of Z. Herrmann being referenced
Efficacy and Safety of Recombinant Human Erythropoietin to Prevent the Anaemias of Prematurity
2015
Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy
1999
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia
1997
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
1996
Effects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma
2002
Prospective Randomized Trial of Dichloromethylene Bisphosphonate (Clodronate) in Patients with Multiple Myeloma Requiring Treatment. A Multicenter Study
1995
The influence of renal function on NT-proBNP levels in various disease groups.
2003